HeartSciences Inc.
Income Statement
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Jan 2025 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1K | $0 | $0 | $2.4K | $1.9K | $0 | $14.7K | $3.9K |
| Cost of Revenue | $760 | $0 | $0 | $1.0K | $760 | $0 | $4.6K | $1.5K |
| Gross Profit | $1.3K | $0 | $0 | $1.4K | $1.1K | $0 | $10.1K | $2.4K |
| Gross Margin | 63.8% | — | — | 58.3% | 60.0% | — | 69.0% | 61.0% |
| Operating Expenses | ||||||||
| Research & Development | $906.6K | $476.2K | $638.6K | $727.0K | $997.2K | $1.0M | $509.5K | $757.3K |
| SG&A Expense | $2.0M | $2.1M | $1.3M | $1.3M | $878.1K | $1.3M | $1.0M | $815.0K |
| Operating Income | $-2.9M | $-2.5M | $-1.9M | $-2.1M | $-1.9M | $-2.4M | $-1.5M | $-1.6M |
| Operating Margin | -139,956.7% | — | — | -85,713.2% | -98,637.8% | — | -10,376.7% | -40,254.9% |
| Interest Expense | — | — | — | — | — | — | $118.4K | $178.4K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-3.2M | $-2.8M | $-2.0M | $-2.4M | $-2.1M | $-2.5M | $-1.6M | $-1.7M |
| Net Margin | -151,064.0% | — | — | -97,179.4% | -108,157.6% | — | -11,182.4% | -44,830.2% |
| EPS (Basic) | $-0.86 | $-0.42 | $-0.21 | $-0.28 | $-0.53 | $-0.29 | $-0.08 | $-0.44 |
| EPS (Diluted) | — | — | — | $-0.28 | $-0.53 | $-0.29 | $-0.08 | $-0.44 |
| Shares Outstanding (Basic) | 3.7M | 2.6M | 9.5M | 8.3M | 3.9M | 8.9M | 19.7M | 4.0M |
| Shares Outstanding (Diluted) | 3.7M | 2.6M | 9.5M | 8.3M | 3.9M | 8.9M | 19.7M | 4.0M |
| Dividends Per Share | $0.00 | — | — | — | — | — | — | — |